Applied Dna Sciences Operating Income

Applied Dna Sciences (APDN) currently reports a operating income of $-35M as of March 2026. That compares with $-13M in the prior-year period — down 168.9% year over year. Use the charts on this page to explore Applied Dna Sciences's operating income history and peer comparisons.

Applied Dna Sciences's operating income decreased from $-13M to $-35M — a 168.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Dna Sciences reported $-35M in operating income as of March 2026. That compares with $-13M in the prior-year period — down 168.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Dna Sciences, and consider following APDN for alerts when major investors trade the stock.

Applied Dna Sciences is classified in the Materials sector. On operating income, it currently shows $-35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing APDN with unrelated industries.